49 results
Page 2 of 3
424B5
qvtk auo27t
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
bseu3h mnsx
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
aio3xtjbw2z9d
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-1.1
fcseyz4jswzr dnha
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
lijoe4nf86chds5m
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
fgdeue4xex9s69cf004w
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
hib67ofckmasrlt2d
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
rovhj9xlnm9hj
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
d4f a7ggylfs
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
lpubez5 ajdel13
10 Jul 19
Prospectus supplement
8:18am
F-3
u692ku7r 01z
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
ftyv6spjuoqr5v0r13z
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
pao mvln128vi
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
cego3sn6
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.2
y2w3y0
19 Nov 18
Agreement and Plan of Merger
4:34pm